Dongcheng Biochem: Jiangxi Yichun Nuclear Medicine Production Center Commences Operations
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, Dongcheng Biochem announced that its wholly-owned subsidiary, Jiangxi Andike Pharmaceutical Co., Ltd. (referred to as "Jiangxi Andike"), has received the "Drug GMP Compliance Inspection Result Notification" issued by the Jiangxi Provincial Drug Administration, adding the Jiangxi Yichun Nuclear Medicine Production Center
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments